Leyson, Gina M.
HRN: 26-51-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2025
AZITHROMYCIN 500MG TABLET (TAB)
01/21/2025
01/18/2025
ORAL
500MG
OD
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes